Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Monique Janssens »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Monique J. Roobol < Monique Janssens < Monique L. Den Boer  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
002A86 (1998) Frans J. M. Debruyne [Pays-Bas] ; Robin Murray [Australie] ; Yves Fradet [Canada] ; Jan E. Johansson [Suède] ; Chris Tyrrell [Royaume-Uni] ; Francesco Boccardo [Italie] ; Louis Denis [Belgique] ; J. Michael Marberger [Autriche] ; Daniel Brune [France] ; Jens Rassweiler [Allemagne] ; Tony Vangeneugden [Belgique] ; Jan Bruynseels [Belgique] ; Monique Janssens [Belgique] ; Peter De Porre [Belgique]Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate

List of associated KwdEn.i

Nombre de
documents
Descripteur
1Academisch ziekenhuis
1Adenocarcinoma
1Advanced stage
1Adverse events
1Alkaline phosphatase
1Androgen blockade
1Antiandrogen
1Antiandrogen withdrawal
1Antiandrogen withdrawal effect
1Antiandrogens
1Antihormone
1Baseline
1Baseline ecog performance status
1Baseline ecog score
1Baseline performance status
1Baseline prognostic factors
1Blood pressure
1Body weight
1Bone pain
1Cancer cells
1Chemotherapy
1Clin
1Clin oncol
1Clinical progression
1Clinical trial
1Common reasons
1Comparative study
1Continuous progression
1Cyproterone
1Cyproterone acetate
1Differentiation therapy
1Ecog
1Ecog performance status
1Elsevier science
1Elteren test
1Endocrine therapy
1Flic
1Freedom fields hospital
1General association
1Group months
1Hair loss
1Hazard ratio
1Heart rate
1Human
1Independent prognostic factors
1Istituto nazionale ricerca cancro
1Janssen research foundation
1Landmark analysis
1Less pain
1Liarozole
1Liarozole group
1Liarozole study group
1Life expectancy
1Lower risk
1Maccallum cancer institute
1Median
1Median crude
1Median duration
1Median months
1Median survival
1Median time
1Median weight
1Medical center hospital
1Metastatic
1Metastatic disease
1Metastatic prostate cancer
1Nail disorders
1Nonresponders
1Oncol
1Pain score
1Pain scores
1Performance status
1Previous therapy
1Private practice
1Prognostic
1Prognostic factors
1Progression
1Prostate
1Prostate cancer
1Prostatic cancer
1Quebec city
1Randomization
1Regression model
1Responder
1Response rate
1Retinoic
1Retinoic acid
1Retinoic acid agent
1Risk group
1Risk groups
1Safety assessments
1Stadtkrankenhaus heilbronn
1Statistical analysis
1Surgical castration
1Surrogate marker
1Survival advantage
1Survival time
1Survival times
1Treatment efficiency
1Treatment group

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Monique Janssens" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Monique Janssens" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Monique Janssens
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024